In Alzheimer's disease and preclinical models, raised ketone levels protect against amyloid-β toxicity and deposition and provide cognitive benefits.
These properties make ketones an attractive means to address the diminished cerebral glucose metabolism (DCGM).
Axona is a prescription medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer’s disease.
Read more about ketones and Axona,
and help for people with mild to moderate Alzheimer’s disease:
To learn more about Alzheimers and Dementia care visit the Alzheimer's Reading Room